New York, NY – GDS Development Management (GDSNY) and Corem AB announced today that they have signed a five-year lease at 28&7 with Injective Labs. Injective has taken 8,685 square feet of office space on the full 10th floor of this SOM-designed building. This new lease is another in a series of Web3, institutional finance firms, creative agencies, and media companies coming to GDSNY properties across the city.
Injective Labs is a research and development company focused on creating Web3 infrastructure for Injective, a blockchain optimized for building financial applications. Injective today is one of the largest blockchains in history, having processed nearly 1 billion transactions across a diverse array of decentralized applications such as exchanges, payment gateways, asset tokenization platforms, lending protocols, and more. Injective Labs is the first company to be incubated by Binance and to date has raised $56 Million from prominent investors such as Pantera Capital and Mark Cuban.
28&7 is a new 12-story, class-A office building at the corner of 28th Street and 7th Avenue in the Penn District, one of New York City’s most dynamic neighborhoods, which has attracted major tenants like Amazon, Apple and Facebook. Designed by Skidmore, Owings & Merrill, the building features a modern grid of hand-crafted black terracotta, large triple-glazed windows, and panoramic views of the city. The building is LEED-Gold certified and offers the very latest in touchless technology and air quality.
“We are happy to report that there is a lot of leasing activity and are very excited to welcome another incredible finance & technology firm to our building,” says Michael Kirchmann, CEO at GDSNY. “With every new tenant, 28&7 continues to solidify its place as a new finance, media and technology headquarters in Manhattan.”
The Landlord was represented by Ethan Silverstein, Michael Movshovich, Grant Potter, and Connor Daugstrup of Cushman Wakefield.
The Tenant was represented by Steven Evans of Platinum Properties.
